Transgenic animals with disrupted npy y1 receptor genes
CA 2271237 A1 · Owner: B.M.R.A. Corp. B.V. · Inventors: Pedrazzini, Thierry; Brunner, Hans R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed to transgenic animals which have been engineered by homologous recombination to be deficient in the expression of the neuropeptide Y Y1 receptor. The invention encompasses the DNA constructs and engineered embryonic stem cells used to produce the animals the , transgenic animals themselves, and assays which utilize either the animals or tissues derived from the animals.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 14, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 14, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 14, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.